PAM
IPSC icon

Panagora Asset Management’s Century Therapeutics IPSC Stock Holding History

Panagora Asset Management’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-90,739
Closed -$43.2K – 1158
2025
Q1 		$43.2K Sell
90,739
-1,016
-1% -$763 ﹤0.01% 1092
2024
Q4 		$92.7K Buy
+91,755
New +$125K ﹤0.01% 1118

Other funds holding IPSC

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Panagora Asset Management's IPSC Position: Q2 2025 in Review

Panagora Asset Management sold out of Century Therapeutics (IPSC) in Q2 2025, closing a stake of 90,739 shares — an estimated $43.2K sold.

Panagora Asset Management first reported a position in IPSC in Q4 2024 and held it in 2 quarters. The position peaked at $92.7K in Q4 2024. 65 funds tracked by Wall St. Rank hold IPSC as of Q2 2025.

  • Panagora Asset Management reported no remaining Century Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Panagora Asset Management sold 90,739 Century Therapeutics shares in Q2 2025, an estimated $43.2K.
  • Panagora Asset Management first reported a position in Century Therapeutics in Q4 2024 and held it in 2 quarters.
  • Panagora Asset Management's Century Therapeutics position peaked at $92.7K in Q4 2024.
  • 65 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2025.

Based on Panagora Asset Management's 13F filing for Q2 2025, filed 13 Aug 2025.